Nancy J Hutson Biocryst Pharmaceuticals Inc (BCRX) insider trading activity

BCRX Quotes by TradingView

Nancy J Hutson is Director of BIOCRYST PHARMACEUTICALS INC. Currently has a direct ownership of 99,138 shares of BCRX, which is worth approximately $1 Million. The most recent transaction as insider was on Jun 12, 2025, when has been sold 12,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 99.1K
14.43% 3M change
5.87% 12M change
Total Value Held $1 Million

Nancy J Hutson Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 12 2025
BUY
Grant, award, or other acquisition
-
12,500 Added 11.2%
99,138 Common Stock
Dec 13 2024
SELL
Open market or private sale
$52,780 $7.54 p/Share
7,000 Reduced 7.48%
86,638 Common Stock
Jun 12 2024
BUY
Grant, award, or other acquisition
-
6,820 Added 6.79%
93,638 Common Stock
May 20 2024
BUY
Open market or private purchase
$31,900 $6.38 p/Share
5,000 Added 5.45%
86,818 Common Stock
Jun 14 2023
SELL
Open market or private sale
$103,442 $8.04 p/Share
12,866 Reduced 13.59%
81,818 Common Stock
Jun 13 2023
BUY
Grant, award, or other acquisition
-
16,745 Added 15.03%
94,684 Common Stock
Jun 07 2022
BUY
Grant, award, or other acquisition
-
12,866 Added 14.17%
77,939 Common Stock
Oct 15 2021
SELL
Open market or private sale
$1,617,000 $15.4 p/Share
105,000 Reduced 61.74%
65,073 Common Stock
Oct 15 2021
BUY
Exercise of conversion of derivative security
$340,200 $3.24 p/Share
105,000 Added 38.17%
170,073 Common Stock
Jun 10 2021
SELL
Open market or private sale
$393,394 $16.86 p/Share
23,333 Reduced 26.39%
65,073 Common Stock
Jun 10 2021
BUY
Exercise of conversion of derivative security
$72,099 $3.09 p/Share
23,333 Added 20.88%
88,406 Common Stock
May 28 2021
BUY
Grant, award, or other acquisition
$4,999 $15.77 p/Share
317 Added 0.48%
65,073 Common Stock
Feb 26 2021
BUY
Grant, award, or other acquisition
$4,991 $10.78 p/Share
463 Added 0.71%
64,756 Common Stock
Nov 30 2020
BUY
Grant, award, or other acquisition
$4,998 $5.11 p/Share
978 Added 1.5%
64,293 Common Stock

Also insider at

CLSD
Clearside Biomedical, Inc. Healthcare
PHAS
PhaseBio Pharmaceuticals Inc Healthcare
Director
ENDP
Endo International plc Healthcare
Director
NJH

Nancy J Hutson

Director
Stonington, CT

Track Institutional and Insider Activities on BCRX

Follow BIOCRYST PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BCRX shares.

Notify only if

Insider Trading

Get notified when an Biocryst Pharmaceuticals Inc insider buys or sells BCRX shares.

Notify only if

News

Receive news related to BIOCRYST PHARMACEUTICALS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BCRX